Table 1.
Tumor origin |
% | |
---|---|---|
PRAK+/+
(n=15) |
Myeloid* | 80.0 % |
Lymphoid | 20.0 % | |
PRAK+/−
(n=33) |
Myeloid | 90.9 % |
Lymphoid | 9.1 % | |
PRAK−/−
(n=9) |
Myeloid | 77.8 % |
Lymphoid | 22.2 % | |
p53+/−
(n=22) |
Myeloid | 54.5 % |
Lymphoid | 45.5 % |
Tumor origin |
% | |
---|---|---|
PRAK+/+
(n=15) |
Myeloid* | 80.0 % |
Lymphoid | 20.0 % | |
PRAK+/−
(n=33) |
Myeloid | 90.9 % |
Lymphoid | 9.1 % | |
PRAK−/−
(n=9) |
Myeloid | 77.8 % |
Lymphoid | 22.2 % | |
p53+/−
(n=22) |
Myeloid | 54.5 % |
Lymphoid | 45.5 % |